Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Circulating mitochondria in deceased organ donors are associated with immune activation and early allograft dysfunction
Justin Pollara, R. Whitney Edwards, Liwen Lin, Victoria A. Bendersky, Todd V. Brennan
Justin Pollara, R. Whitney Edwards, Liwen Lin, Victoria A. Bendersky, Todd V. Brennan
View: Text | PDF
Research Article Inflammation Transplantation

Circulating mitochondria in deceased organ donors are associated with immune activation and early allograft dysfunction

  • Text
  • PDF
Abstract

Brain death that occurs in the setting of deceased organ donation for transplantation is associated with systemic inflammation of unknown origin. It has recently been recognized that mitochondria-derived damage-associated molecular patterns (mtDAMPs) released into the circulation in the setting of trauma and tissue injury are associated with a systemic inflammatory response. We examined the blood of deceased organ donors and found elevated levels of inflammatory cytokines and chemokines that correlated with levels of mtDAMPs. We also found that donor neutrophils are activated and that donor plasma contains a neutrophil-activating factor that is blocked by cyclosporin H, a formyl peptide receptor-1 antagonist. Examination of donor plasma by electron microscopy and flow cytometry revealed that free- and membrane-bound mitochondria are elevated in donor plasma. Interestingly, we demonstrated a correlation between donor plasma mitochondrial DNA levels and early allograft dysfunction in liver transplant recipients, suggesting a role for circulating mtDAMPs in allograft outcomes. Current approaches to prolong allograft survival focus on immune suppression in the transplant recipient; our data indicate that targeting inflammatory factors in deceased donors prior to organ procurement is another potential strategy for improving transplant outcomes.

Authors

Justin Pollara, R. Whitney Edwards, Liwen Lin, Victoria A. Bendersky, Todd V. Brennan

×

Figure 3

Plasma from deceased organ donors is able to induce production of ROS by PMNs from healthy living normal donors.

Options: View larger image (or click on image) Download as PowerPoint
Plasma from deceased organ donors is able to induce production of ROS by...
(A) Example curve of PMN ROS production. Leukocytes from 2 heathy normal donors (NDs) were stimulated with ND plasma (autologous, black line; heterologous, blue line) or plasma from deceased donors (red and purple lines), and ROS production was measured by chemiluminescent detection. Stimulation with N-formylmethionyl-leucyl-phenylalanine (fMLP) is indicated. Data represent the mean and standard error of RLU resulting from oxidation of luminol by ROS. Data points representing the maximum response observed for plasma stimulation and the new set point after plasma and fMLP stimulation along the kinetic curve are indicated. (B) Plasma maximum and (C) new set point ROS production observed for leukocytes from healthy NDs incubated with autologous plasma samples (n = 5), plasma from heterologous NDs (n = 5), or plasma from deceased donors (DBD/DCD, n = 23). In B and C, the gray boxes represent the interquartile range, the lines represent the median, and whiskers indicate the range of observed responses. No significant difference was observed for comparisons between ND and DBD/DCD (Mann-Whitney test). Open symbols in B and C represent samples that induced ROS maximum or set point responses above levels observed for NDs.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts